|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 3.090 USD | -4.04% |
|
-12.22% | -45.50% |
| 05-07 | MannKind Corporation, Q1 2026 Earnings Call, May 06, 2026 | |
| 05-06 | Earnings Flash (MNKD) MannKind Corporation Posts Q1 Adjusted Loss $0.02 per Share | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Bio Therapeutic Drugs
| Capi. | Sales growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 955M | - | - | - | ||
| 50.1B | |||||
| 45.82B | |||||
| 23.66B | - | ||||
| 22.65B | - | ||||
| 17.8B |
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition